Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts

Vaccine

Volumn 21, Issue 13-14, 2003, Pages 1415-1422

  Marchart, J ^a   Rehagen, M ^b   Dropmann, G ^b,f   Szostak, M P ^c,e   Alldinger, S ^d   Lechleitner, S ^a   Schlapp, T ^b   Resch, S ^c   Lubitz, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b BAYER AG   (Germany)

^c Apovia AG   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e BIRD C GmbH and CoKEG   (Austria)

^f INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

Bacterial ghost; Protection; Vaccine

Indexed keywords

BACTERIAL VACCINE; GHOST VACCINE; IMMUNOLOGICAL ADJUVANT; PASTOBOV; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE DISEASE; CONTROLLED STUDY; DEATH; ECONOMIC ASPECT; EXPERIMENTAL MODEL; IMMUNIZATION; INFECTION PREVENTION; MANNHEIMIA HAEMOLYTICA; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION; VALIDATION PROCESS;

ANIMALS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; FERMENTATION; IMMUNIZATION; MANNHEIMIA HAEMOLYTICA; PASTEURELLA INFECTIONS; PLASMIDS;

EID: 0037471417     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00635-7     Document Type: Article

References (16)

1. Carter, GR, Chengapapa, MM, Roberts, AW. Essentials of veterinary microbiology. Baltimore: The Williams & Wilkins Co.; 1995. p. 171-9.
2. Lillie L.E. The bovine respiratory disease complex. Can. Vet. J. 15:1974;233-242.
3. Rutter JM. Pasteurella multocida. In: Adlam C, editor. Pasteurella and pasteurellosis. San Diego: Academic Press; 1989. p. 37-75.
4. Peters A.R. Vaccines for respiratory disease in cattle. Vaccine. 5:1987;164.
5. Moiser D.A., Confer A.W., Panciera R.J. The evolution of vaccines for bovine pneumonic pasteurellosis. Res. Vet. Sci. 47:1989;1-10.
6. Moiser D.A., Simons K.R., Chengapappa M.M., Confer A.W. Antigenic composition of Pasteurella haemolytica serotype-1 supernatants from supplemented and non supplemented media. Am. J. Vet. Res. 55:1994;348-352.
7. Witte A., Wanner G., Bläsi U., Halfman G., Szostak M., Lubitz W. Endogenous transmembrane tunnel formation mediated by φX174 lysis protein E. J. Bacteriol. 172:1990;4109-4114.
8. Lubitz W., Witte A., Eko F.O., Kamal M., Jechlinger W., Brand E.et al. Extended recombinant bacterial ghost system. J. Biotech. 73:1999;261-273.
9. Witte A., Lubitz W. Biochemical characterization of PhiX174 protein E mediated lysis of Escherichia coli. Eur. J. Biochem. 180:1989;393-398.
10. Witte A, Brand E, Schrot G, Lubitz W. Pathway of PhiX174 protein E mediated lysis of E. coli. In: Pedro MA, Höltje JV, Löffelhard W, editors. Bacterial growth and Lysis. New York: Plenum Press; 1993. p. 227-83.
11. Witte A., Wanner G., Lubitz W., Höltje J.V. Effect of PhiX174 E-mediated lysis on murein composition of Escherichia coli. FEMS Microbiol. Lett. 164:1998;149-157.
12. Witte A., Bläsi U., Halfmann G., Szostak M., Wanner G., Lubitz W. PhiX174 protein E-mediated lysis of E. coli. Biochimie. 72:1990;191-200.
13. Witte A., Wanner G., Sulzner M., Lubitz W. Dynamics of PhiX174 protein E-mediated lysis of E. coli. Arch. Microbiol. 157:1992;381-388.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press; 1989.
15. Szostak M.P., Hensel A., Eko F.O., Klein T., Mader H., Haselberger A.et al. Bacterial ghosts: non-living candidate vaccines. J. Biotechnol. 44:1996;161-170.
16. Szostak M, Lubitz W. Recombinant bacterial ghosts as multivaccine - vehicles. In: Channock RM, Ginsberg HS, Brown F, Lerner RA, editors. Vaccines 91: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press; 1991. p. 409-14.